Biblio
33557 resultats trouvés
.
2015.
Randomized Phase III Study of Erlotinib Versus Observation in Patients With No Evidence of Disease Progression After First-Line Platin-Based Chemotherapy for Ovarian Carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Ca. JOURNAL OF CLINICAL ONCOLOGY. 32:320+.
.
2014. Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02). ANNALS OF ONCOLOGY. 27:121-127.
.
2016. Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer. JOURNAL OF CLINICAL ONCOLOGY. 32:76+.
.
2014. Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast Nephropathy. JOURNAL OF CLINICAL ONCOLOGY. 38:2647+.
.
2020. Ranibizumab and exudative age-related macular degeneration: 5-year multicentric functional and anatomical results in real-life practice. JOURNAL FRANCAIS D OPHTALMOLOGIE. 39:668-674.
.
2016. Ranibizumab and exudative age-related macular degeneration: five years multicentric functional and anatomical results in real-life practice in France. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 56
.
2015. Ranibizumab and exudative age-related macular degeneration: five years multicentric functional and anatomical results in real-life practice in France. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 56
.
2015. Ranibizumab in patients with neovascular age-related macular degeneration in real-world clinical settings in France: 1-year data from the LUMINOUS (TM) study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 57
.
2016. Ranibizumab or Aflibercept for Diabetic Macular Edema Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry. OPHTHALMOLOGY. 127:608-615.
.
2020. Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 61
.
2020. Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 61
.
2020. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study). OPHTHALMOLOGY. 125:691-700.
.
2018. Rank two aCM bundles on the del Pezzo fourfold of degree 6 and its general hyperplane section. JOURNAL OF PURE AND APPLIED ALGEBRA. 222:585-609.
.
2018. Rank two aCM bundles on the del Pezzo threefold with Picard number 3. JOURNAL OF ALGEBRA. 429:413-446.
.
2015. Ranking journals: the Best-Worst scaling approach applied to the field of wine economics. APPLIED ECONOMICS. 54:1688-1699.
.
2022. Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy. INTERNATIONAL JOURNAL OF CANCER. 143:3008-3018.
.
2018. Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity. CANCER RESEARCH. 76:4100-4112.
.
2016. Rapid 96-well plates DNA extraction and sequencing procedures to identify genome-wide transposon insertion sites in a difficult to lyse bacterium: Lactobacillus casei. JOURNAL OF MICROBIOLOGICAL METHODS. 106:78-82.
.
2014. Rapid amperometric detection of Escherichia coli in wastewater by measuring beta-D glucuronidase activity with disposable carbon sensors. ANALYTICA CHIMICA ACTA. 892:160-166.
.
2015. Rapid and automatic discrimination between facial expressions in the human brain. NEUROPSYCHOLOGIA. 129:47-55.
.
2019. Rapid and robust on-site evaluation of articulated arm coordinate measuring machine performance. MEASUREMENT SCIENCE AND TECHNOLOGY. 29:115011.
.
2018. Rapid and Sustained Response to Tocilizumab in Patients with Polymyalgia Rheumatica Resistant or Intolerant to Glucocorticoids: A Multicenter Open-label Study. JOURNAL OF RHEUMATOLOGY. 43:249-250.
.
2016. Rapid antibiotic susceptibility testing on blood cultures using MALDI-TOF MS. PLOS ONE. 13:e0205603.
.
2018. Rapid detection and discrimination of chromosome-and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 73:3359-3367.
.
2018.